Philippe Morice Selected Research

Hyperthermic Intraperitoneal Chemotherapy

3/2023	Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.
10/2013	Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Morice Research Topics

Disease

69	Neoplasms (Cancer) 03/2024 - 07/2002
64	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 12/2003
26	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 01/2003
20	Carcinoma (Carcinomatosis) 04/2023 - 12/2003
16	Endometrial Neoplasms (Endometrial Cancer) 04/2023 - 02/2002
12	Ovarian Epithelial Carcinoma 03/2023 - 12/2002
9	Neoplasm Metastasis (Metastasis) 03/2023 - 07/2004
6	Peritoneal Diseases 11/2011 - 09/2002
5	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 07/2013
5	Vaginal Neoplasms (Cancer, Vaginal) 10/2023 - 05/2018
5	Adenocarcinoma 01/2019 - 03/2004
3	Endometrial Stromal Sarcoma 10/2023 - 10/2009
3	Melanoma (Melanoma, Malignant) 04/2023 - 07/2002
3	Infertility (Sterility) 01/2019 - 03/2007
2	Clear Cell Adenocarcinoma 10/2023 - 10/2012
2	Peritoneal Neoplasms 03/2023 - 01/2014
2	Residual Neoplasm 02/2023 - 10/2012
2	Endometriosis 12/2019 - 10/2008
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2012
2	Lymphocele 01/2018 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2007 - 09/2004
1	Lymphatic Metastasis 01/2024
1	Microsatellite Instability 04/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2023
1	Colonic Neoplasms (Colon Cancer) 03/2023
1	Colorectal Neoplasms (Colorectal Cancer) 03/2023
1	Carcinosarcoma 01/2023
1	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 01/2023
1	Uterine Diseases (Endometrial Disease) 09/2022
1	Rupture 12/2021
1	Lymphadenopathy 12/2021
1	Atrophy 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Inflammation (Inflammations) 05/2020
1	Genomic Instability 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Anemia 10/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Leiomyoma (Uterine Fibroids) 01/2017

Drug/Important Bio-Agent (IBA)

7	PlatinumIBA 04/2023 - 07/2004
5	Biomarkers (Surrogate Marker)IBA 05/2021 - 11/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2007
4	lenvatinibIBA 04/2023 - 01/2021
4	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2021
4	pembrolizumabIBA 04/2023 - 01/2021
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2021 - 05/2008
3	Hormones (Hormone)IBA 01/2019 - 02/2010
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2023 - 11/2022
2	Diethylstilbestrol (Stilbestrol)FDA Link 10/2023 - 10/2012
2	Bevacizumab (Avastin)FDA Link 02/2023 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2022
2	AntigensIBA 01/2018 - 07/2002
1	Indicators and Reagents (Reagents)IBA 03/2024
1	dostarlimabIBA 04/2023
1	Phosphotransferases (Kinase)IBA 04/2023
1	Carboplatin (JM8)FDA LinkGeneric 02/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2023
1	cabozantinibIBA 01/2022
1	NivolumabIBA 01/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 11/2020
1	Sunitinib (Sutent)FDA Link 12/2019
1	regorafenibIBA 12/2019
1	Contraceptive Agents (Contraceptives)IBA 03/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Tamoxifen FDA LinkGeneric 01/2017
1	MicroRNAs (MicroRNA)IBA 06/2015

Therapy/Procedure

46	Brachytherapy 01/2024 - 10/2002
29	Drug Therapy (Chemotherapy) 01/2024 - 09/2002
28	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 09/2002
25	Therapeutics 10/2023 - 09/2002
24	Radiotherapy 01/2024 - 10/2002
18	Conservative Treatment 02/2022 - 09/2002
16	Hysterectomy 09/2022 - 02/2002
10	Neoadjuvant Therapy 03/2024 - 02/2008
8	Adjuvant Chemotherapy 01/2023 - 01/2003
8	Cytoreduction Surgical Procedures 01/2018 - 07/2009
7	Chemoradiotherapy 05/2022 - 04/2005
6	Operative Surgical Procedures 12/2015 - 09/2002
4	Immunotherapy 04/2023 - 03/2006
4	Trachelectomy 10/2021 - 03/2004
4	Salpingo-oophorectomy 01/2018 - 11/2009
3	Palliative Care (Palliative Therapy) 03/2023 - 01/2021
3	Contraindications 01/2019 - 02/2013
3	Combined Modality Therapy 01/2017 - 02/2015
2	Hyperthermic Intraperitoneal Chemotherapy 03/2023 - 10/2013
2	Precision Medicine 01/2023 - 12/2012
2	Laparotomy 12/2021 - 11/2013
2	Hormonal Contraception 01/2019 - 03/2018
2	Contraception (Birth Control) 01/2019 - 03/2018
2	Morcellation 01/2017 - 06/2014
2	Cystectomy 03/2012 - 05/2006
2	Curettage 01/2005 - 12/2002
1	Re-Irradiation 03/2021
1	Ileostomy 01/2018
1	Perioperative Care 11/2016